Mair D D, Seward J B, Driscoll D J, Danielson G K
Circulation. 1985 Sep;72(3 Pt 2):II70-6.
Between April 1972 and August 1984, 72 patients with Ebstein's malformation underwent surgery at a Mayo Clinic-affiliated hospital. In 58 (81%), plastic reconstruction of the tricuspid valve in which the anterior leaflet was used as a monocusp valve was possible. Eleven patients (15%) required a prosthetic valve (Hancock in 10; Starr-Edwards in one), and in three patients who had received a previous Glenn anastomosis, conversion to a Fontan type of arrangement was carried out. Age at operation ranged from 11 months to 64 years. There were five hospital deaths (6.9%) and three late, presumably arrhythmic, deaths. Follow-up of the initial 39 surgical survivors at least 2 years after the operation (mean, 5 years) revealed that 87% were in functional NYHA class I or II, a marked improvement over preoperative status. Surgical intervention is now recommended for all Ebstein's patients whose symptoms have deteriorated to NYHA class III or further. In addition, elective operation is recommended for less symptomatic patients in whom the cardiothoracic ratio has reached 0.65 or who are significantly cyanotic and polycythemic secondary to right-to-left shunting through an associated atrial septal defect.
1972年4月至1984年8月期间,72例埃布斯坦畸形患者在梅奥诊所附属医院接受了手术。其中58例(81%)可行三尖瓣整形重建术,即将前叶用作单叶瓣膜。11例患者(15%)需要植入人工瓣膜(10例植入汉考克瓣膜;1例植入斯塔尔-爱德华兹瓣膜),3例曾接受过格伦吻合术的患者则转为Fontan术式。手术年龄从11个月至64岁不等。有5例患者术后死亡(6.9%),另有3例晚期死亡,推测与心律失常有关。对最初39例手术存活患者术后至少2年(平均5年)的随访显示,87%的患者心功能处于纽约心脏协会(NYHA)I级或II级,较术前状况有显著改善。现在建议对所有症状已恶化至NYHA III级或更严重的埃布斯坦畸形患者进行手术干预。此外,对于症状较轻但心胸比率已达0.65的患者,或因相关房间隔缺损导致右向左分流而出现明显发绀和红细胞增多症的患者,建议进行择期手术。